BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5602142)

  • 21. Changes in histamine synthetic activity, histamine content and responsiveness to compound 48/80 with maturation of rat peritoneal mast cells.
    Beaven MA; Aiken DL; Woldemussie E; Soll AH
    J Pharmacol Exp Ther; 1983 Mar; 224(3):620-6. PubMed ID: 6827484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No effect of heparin on IgE-dependent and IgE-independent histamine release in human skin in vivo: a microdialysis study.
    Petersen LJ; Skov PS
    J Dermatol Sci; 2006 Nov; 44(2):123-5. PubMed ID: 17008062
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.
    He S; Gaça MD; Walls AF
    J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of immunomodulators that stimulate macrophagal functional activity on the morphofunctional characteristics of mast cells].
    Bochkarev VA; Kupriianov VS
    Tsitologiia; 1994; 36(9-10):960-5. PubMed ID: 7701624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pycnogenol inhibits the release of histamine from mast cells.
    Sharma SC; Sharma S; Gulati OP
    Phytother Res; 2003 Jan; 17(1):66-9. PubMed ID: 12557250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
    He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of the electrophoretic mobility distribution of rat mast cells after immunologic activation.
    Petty HR; Ware BR; Wasserman SI
    Biophys J; 1980 Apr; 30(1):41-50. PubMed ID: 7260269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanisms of the modulating effect of mast cells on the leukocytic response in inflammation].
    Klimenko NA; Pyshnov GIu
    Biull Eksp Biol Med; 1993 Jan; 115(1):29-30. PubMed ID: 8054568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.
    Addington AK; Johnson DA
    Biochemistry; 1996 Oct; 35(42):13511-8. PubMed ID: 8885830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mode of binding and release of histamine in mast cell granules from the rat.
    Uvnäs B
    Fed Proc; 1967; 26(1):219-21. PubMed ID: 6018924
    [No Abstract]   [Full Text] [Related]  

  • 32. Mast cell disruption and other changes in the pericorneal tissue morphology after intraperitoneal injections of a potent histamine liberator (compound 48/80).
    Garden JW
    Invest Ophthalmol; 1965 Oct; 4(5):835-43. PubMed ID: 5831991
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of methylmercury on histamine release from rat mast cells.
    Graevskaya EE; Yasutake A; Aramaki R; Rubin AB
    Arch Toxicol; 2003 Jan; 77(1):17-21. PubMed ID: 12491036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mode of action of protamine sulfate on histamine secretion in the rat mast cells].
    Schnitzler S; Steinhauser G; Renner H; Grochalski G
    Acta Biol Med Ger; 1980; 39(10):1037-44. PubMed ID: 6164192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Morphometric analysis of a mast cell population].
    Linder DP; Poberiĭ IA; Rozkin MIa; Efimov VS
    Arkh Patol; 1980; 42(6):60-4. PubMed ID: 6998431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cell depleting properties of neomycin.
    Raab WP
    J Invest Dermatol; 1968 Feb; 50(2):138-40. PubMed ID: 5641643
    [No Abstract]   [Full Text] [Related]  

  • 37. Degranulation, density, and distribution of mast cells in the rat thalamus: a light and electron microscopic study in basal conditions and after intracerebroventricular administration of nerve growth factor.
    Florenzano F; Bentivoglio M
    J Comp Neurol; 2000 Sep; 424(4):651-69. PubMed ID: 10931487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histamine modulates mast cell degranulation through an indirect mechanism in a model IgE-mediated reaction.
    Carlos D; Sá-Nunes A; de Paula L; Matias-Peres C; Jamur MC; Oliver C; Serra MF; Martins MA; Faccioli LH
    Eur J Immunol; 2006 Jun; 36(6):1494-503. PubMed ID: 16703563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction.
    Assem el-SK; Peh KH; Wan BY; Middleton BJ; Dines J; Marson CM
    Int Immunopharmacol; 2008 Dec; 8(13-14):1793-801. PubMed ID: 18805511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the effect of mast cell granules on lymphocyte blastogenesis in the absence and presence of mitogens: identification of heparin as a granule-associated suppressor factor.
    Frieri M; Metcalfe DD
    J Immunol; 1983 Oct; 131(4):1942-8. PubMed ID: 6413584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.